Country | Total health expenditure as % of gross domestic product | Public health expenditure as % of total health expenditure | National TB programme | Central unit | TB control and elimination plan | Specific targets for TB control and elimination | Specific TB budget | Laboratory external quality assessment system | Individual case-based electronic database | Directly observed treatment for all or selected patients | Free TB diagnosis | Free TB treatment | Special incentive/enabler for some or all TB patients |
Australia | 9 | 68 | No | No | Yes | Yes | No | Yes | Yes | Selected | Yes, all tested | Yes | No |
Austria | 9 | 76 | NA | NA | NA | NA | NA | NA | NA | Selected | NA | NA | NA |
Belgium | 11 | 76 | No | No | No | No | Yes | Yes | Yes | Selected | Yes, all tested | Yes | No |
Canada | 11 | 70 | No | No | Yes | Yes | No | Yes | No | Selected | Yes, all tested | Yes | No |
Cuba | 10 | 95 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | All | Yes, all tested | Yes | Yes |
Cyprus | 7 | 43 | No | No | No | No | No | Yes | Yes | All | Yes, if confirmed | Yes | No |
Czech Rep. | 7 | 84 | No | No | No | No | No | Yes | Yes | Selected | Yes, all tested | Yes | No |
Denmark | 11 | 85 | No | No | No | No | No | Yes | Yes | Selected | Yes, all tested | Yes | No |
Finland | 9 | 75 | Yes | No | Yes | No | No | Yes | Yes | Selected | Yes, all tested | Yes | No |
France | 12 | 77 | Yes | Yes | Yes | No | Yes | Yes | Yes | Selected | Yes, all tested | Yes | No |
Germany | 11 | 76 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Selected | Yes, all tested | Yes | No |
Greece | 11 | 61 | No | No | No | No | No | Yes | Yes | NA | Yes, other criteria | No# | No |
Ireland | 9 | 70 | Yes | No | No | No | No | Yes | Yes | Selected | Yes, all tested | No¶ | Yes |
Israel | 8 | 62 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | All | Yes, all tested | Yes | Yes |
Malta | 9 | 66 | Yes | Yes | Yes | Yes | No | No | Yes | Selected | Yes, all tested | Yes | Yes |
Netherlands | 12 | 86 | No | Yes | Yes | No | No | No | Yes | Selected | Yes, other criteria+ | No+ | Yes |
Norway | 9 | 86 | No | Yes | No | No | No | Yes | Yes | Selected | Yes, all tested | Yes | Yes |
Slovakia | 9 | 64 | Yes | Yes | Yes | No | Yes | Yes | Yes | Selected | Yes, all tested | Yes | No |
Slovenia | 9 | 73 | No | No | Yes | Yes | No | Yes | Yes | NA | Yes, all tested | Yes | No |
Sweden | 9 | 81 | No | No | No | No | No | Yes | Yes | No policy | Yes, all tested | Yes | No |
Switzerland | 11 | 65 | Yes | Yes | Yes | No | Yes | Yes | Yes | Selected | No | No | Yes |
USA | 18 | 46 | Yes | Yes | Yes | Yes | Yes | No | Yes | Selected | Yes, all tested | Yes | Yes |
Data concern national levels. Based on the roles and responsibilities for the organisation and delivery of health services, country-level responses need to be interpreted with caution, especially for countries with a federal system of government. NA: not available or no answer. #: patient pays 25%; ¶: nominal fee of €1.50 on each medication dispensed; +: covered by health insurance, but patients must pay the first €350 of healthcare costs.